Publications

Journal Article Ppublish 499 citations
Electronic publication date
July 31, 2012

View on Pubmed.gov 22844547 | View on doi.org 10.4251/wjgo.v4...

Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Search for publications in this journal World J Gastrointest Oncol - 4(7):156-69

Abstract

Carcinoma of the stomach is still the second most common cause of cancer death worldwide, although the incidence and mortality have fallen dramatically over the last 50 years in many regions. The incidence of gastric cancer varies in different parts of the world and among various ethnic groups. Despite advances in diagnosis and treatment, the 5-year survival rate of stomach cancer is only 20 per cent. Stomach cancer can be classified into intestinal and diffuse types based on epidemiological and clinicopathological features. The etiology of gastric cancer is multifactorial and includes both dietary and nondietary factors. The major diet-related risk factors implicated in stomach cancer development include high content of nitrates and high salt intake. Accumulating evidence has implicated the role of Helicobacter pylori (H. pylori) infection in the pathogenesis of gastric cancer. The development of gastric cancer is a complex, multistep process involving multiple genetic and epigenetic alterations of oncogenes, tumor suppressor genes, DNA repair genes, cell cycle regulators, and signaling molecules. A plausible program for gastric cancer prevention involves intake of a balanced diet containing fruits and vegetables, improved sanitation and hygiene, screening and treatment of H. pylori infection, and follow-up of precancerous lesions. The fact that diet plays an important role in the etiology of gastric cancer offers scope for nutritional chemoprevention. Animal models have been extensively used to analyze the stepwise evolution of gastric carcinogenesis and to test dietary chemopreventive agents. Development of multitargeted preventive and therapeutic strategies for gastric cancer is a major challenge for the future.

References

N Engl J Med. 2001 Sep 13;345(11):784-9

Nat Genet. 2004 Dec;36(12):1243-4

Toxicol Pathol. 2010 Jan;38(1):188-97

Helicobacter. 2006 Aug;11(4):272-86

Cited by 499 citations (total)

Journal Article Review

Brain metastases in gastrointestinal cancers: is there a role for surgery?

Electronic publication date June 24, 2015

Search for publications in this journal Int J Mol Sci

Johannes Lemke [...] Marko Kornmann et al.

About 10% of all cancer patients will develop brain metastases during advanced disease progression. Interestingly, the vast majority of brain...

Journal Article Review

COX-2 Inhibitors and Gastric Cancer.

Electronic publication date November 6, 2014

Search for publications in this journal Gastroenterol Res Pract

Zhen Wang [...] Jin-Lu Liu et al.

The evidence that cyclooxygenase-2 (COX-2) is upregulated and plays an important role in carcinogenesis of gastric cancer has triggered the...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties